Blueprint Medicines
BPMC
$105.56
Share price
-0.75%
Change (1 day)
85.88%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Total debt
Total debt on the balance sheet as of March 2024 : $0.33 B
According to Blueprint Medicines 's latest financial reports the company's total debt is $0.33 B. A company’s total debt is the sum of all current and non-current debts.
Blueprint Medicines - Total debt on balance sheet (from 2014 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.33 B | 37.14% |
| 2022-12-31 | $0.24 B | 117.62% |
| 2021-12-31 | $0.11 B | 24.33% |
| 2020-12-31 | $89.6 M | -6.61% |
| 2019-12-31 | $95.94 M | 556.42% |
| 2018-12-31 | $14.61 M | -18.11% |
| 2017-12-31 | $17.84 M | 139.94% |
| 2016-12-31 | $7.43 M | -34.09% |
| 2015-12-31 | $11.28 M | 24.82% |
| 2014-12-31 | $9.04 M | 215.82% |
| 2013-12-31 | $2.86 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | $0.93 B | 182.13% | 🇺🇸 USA |
 OPKO Health
OPK | $0.41 B | 27.10% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 Isoray
ISR | $0.39 M | -99.88% | 🇺🇸 USA |